NCT02845154

Brief Summary

Post-reperfusion syndrome and ischemia-reperfusion insult are a common well-known complication in liver transplantation. Several trials investigated variables that my contribute to the generation of these two complications for reducing their incidence and magnitude. The investigators will investigate the effect of acute conditioning of the recipients circulation to the vasoactive mediators in the graft as well as the congested intestine through intermittent purging of graft contents into the patient's systemic circulation in living donor liver transplantation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2015

Typical duration for not_applicable

Geographic Reach
1 country

3 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

October 16, 2015

Completed
10 months until next milestone

First Posted

Study publicly available on registry

July 27, 2016

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

March 27, 2017

Status Verified

December 1, 2016

Enrollment Period

1.8 years

First QC Date

October 16, 2015

Last Update Submit

March 24, 2017

Conditions

Keywords

Ischemia reperfusionpost-reperfusion syndromeliving donor liver transplantationpatient outcome

Outcome Measures

Primary Outcomes (1)

  • Post-reperfusion syndrome

    Reduced Mean arterial blood pressure to the predefined value

    5 minutes after portal declamping

Secondary Outcomes (3)

  • Graft ischemia reperfusion injury

    one week post-operative

  • Severity of post-reperfusion syndrome

    5 minutes after portal declamping

  • One month patient mortality

    one month post-operative

Study Arms (2)

Control (bolus purge)

ACTIVE COMPARATOR

The portal vein clamp will be totally released after end of portal vein anastomosis and all graft and portal blood contents are allowed free and complete access to the systemic circulation via the inferior vena cave

Other: bolus purge

Intermittent Purge

EXPERIMENTAL

The portal clamp will be released in situ for 5 seconds to allow purge of the graft and portal contents into the systemic circulation, followed by 30 seconds of portal clamping again. This will be followed by another two cycles of 5 seconds declamping and 30 seconds clamping , then, the portal clamp will be completely released.

Other: Intermittent purge

Interventions

complete and uninterrupted purge

Control (bolus purge)

intermittent portal purge

Intermittent Purge

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • living donor liver transplantation recipients

You may not qualify if:

  • Non

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Liver transplantation program - Gastroenterology surgical center

Al Mansurah, Dakahlia Governorate, 35511, Egypt

RECRUITING

Liver transplantation project - Gastroenterology surgical center - Mansoura university

Al Mansurah, Dakahlia Governorate, 35511, Egypt

RECRUITING

Gastroenterology surgical center - Mansoura university

Al Mansurah, Dakahlia Governorate, 35516, Egypt

RECRUITING

MeSH Terms

Conditions

HypotensionReperfusion Injury

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Amr M Yassen, MD

    Mansoura Faculty of Medicine

    STUDY DIRECTOR

Central Study Contacts

Amr M Yassen, MD

CONTACT

Adel A Hassan, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Anesthesia and Intensive Care

Study Record Dates

First Submitted

October 16, 2015

First Posted

July 27, 2016

Study Start

October 1, 2015

Primary Completion

August 1, 2017

Study Completion

November 1, 2017

Last Updated

March 27, 2017

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations